|View printer-friendly version|
|Illumina Announces BaseSpace® Pricing for Data Storage and Processing|
Breaks Analysis Cost Bottleneck for Next Generation Sequencing Workflow
Every BaseSpace account will now include 1 terabyte (TB) of free storage
In the fall, through BaseSpace Apps, every BaseSpace user will have the ability to run analysis applications on an “as-needed” basis, developed by both open source and third-party developers. These applications can be purchased “on the fly” and per analysis, allowing users to affordably run new analysis strategies without investing in dedicated software or hardware infrastructure. BaseSpace Apps will include a diverse and growing set of industry leading data analysis and visualization applications for both MiSeq and HiSeq data analysis. The price for running a BaseSpace App will be set directly by each developer.
“Illumina is taking huge strides to eliminate the much publicized ‘data
deluge’ and data analysis bottleneck. The adoption of BaseSpace thus far
has been exciting to watch, with the vast majority of MiSeq systems now
connected, and already half of those actively uploading data," said
“BaseSpace has made it easy to share data with our collaborators and
customers,” said Dr.
Already compatible with Illumina’s MiSeq system, BaseSpace will become available for use with the Company’s HiSeq systems early in the fourth quarter of 2012, offering the same benefits of seamless real-time data transfer, assembly and variant detection for fast, high quality genome processing. BaseSpace Apps will also become available to customers in the fourth quarter.
Illumina’s pricing plan for BaseSpace is effective immediately. For more information, visit www.illumina.com/BaseSpace.
This release contains forward looking statements that involve risks and
uncertainties. Examples of forward-looking statements include, but are
not limited to, statements we make regarding the expected availability
dates for certain BaseSpace services and Apps. Important factors that
could cause actual results to differ materially from those in any
forward-looking statements include challenges inherent in developing,
manufacturing, and launching new products and services and the other
factors that are detailed in our filings with the